Determinants of End-of-life Place of Care for Children Suffering From Cancer.
NCT ID: NCT02060578
Last Updated: 2015-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2014-01-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pediatric guidelines about the place of end-of-life care are varied. On European scale, home is recommended (IMPaCCT study, 2007). In France, the 2008-2012 palliative care development program recommended home or initial hospital care unit. This program also supports implementation of mobile team rather than specific hospital units.
In Brittany, a pattern of regional palliative care resource team has been implemented since 2005. In oncology, further to the guidelines, end-of-life place of care is often discussed several times for each case. Sometimes occur a lot of returns between home and hospital, psychological difficulties, and difficulties to offer adapted care conditions. Finally, less than 30% of children in palliative care decease at home.
The primary objective is to identify main determinants of the place of palliative care in pediatric oncology.
The secondary objective is to clarify the factors of change comparing to the initial planned place.
Intervention :
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Number of subjects is : Parents of 68 to 93 children who died from cancer after a palliative phase, that means 136 to 186 parents.
Expected results and perspectives :
Using both quantitative and qualitative methods, expected results are the followings:
* Identification of the objective and subjective factors, which influenced the decision of the place of care.
* Determination of the factors of change comparing to the initial planned place.
Once identified, main factors could be the ones to pay attention to in order to help for initial decision, better anticipation of change of place and better guidance of palliative care organization wherever, at home or in hospital.
Results would be new information for research on palliative care for children but also for adults.
Finally, this work is part of an improving approach of palliative care, related to the development of open-care hospital networks. We can expect some public health impacts with new arguments to help for complementary recommendations.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion criteria are :
Parents of a deceased child
* From cancer, after palliative phase
* Age of death under 18 years old.
* Death occurred in Brittany
* Death between 2005 and 2010
Exclusion criterium is :
Parents of child who deceased after 2010 (respecting a bereavement delay)
Outcomes measures :
Primary study endpoint : Consideration or not by parents that they and/or their child had the choice of the end-of-life place of care.
Secondary study endpoints :
* objective factors : grade, occupational categories, marital status of parents, siblings, home conditions, access to the hospital, meeting with a professional of palliative care network, helpful general practitioner, volunteers, psychological support but also unexpected symptoms, needed nursing care which can explain a return from home to hospital for instance.
* subjective factors such as family or religious values, needs of intimacy, communication, support, sense of security, anxiety, fear, doubts about the next events.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Questionnaire and interview
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire and interview
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* From cancer, after palliative phase
* Age of death under 18 years old.
* Death occurred in Brittany
* Death between 2005 and 2010
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rennes 2
OTHER
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Robert
Role: PRINCIPAL_INVESTIGATOR
Rennes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rennes University Hospital
Rennes, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13.04.08
Identifier Type: OTHER
Identifier Source: secondary_id
13.428
Identifier Type: OTHER
Identifier Source: secondary_id
913434
Identifier Type: OTHER
Identifier Source: secondary_id
35RC13_9749_DELI-DEVI
Identifier Type: -
Identifier Source: org_study_id